Differences in D-dimer blood concentration in atrial fibrillation patients with left atrial thrombus or severe left atrial spontaneous echo contrast. 2022

Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
Department of Cardiology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin Er Road, Shanghai, 200025, China.

OBJECTIVE Severe left atrial spontaneous echo contrast (SLASEC) is considered the prior stage to thrombosis and a high-risk factor for thrombotic events. Studies have suggested an effect of D-dimer blood concentration on exclusion of left atrial thrombus (LAT), but it remains unclear whether D-dimer concentrations differ between atrial fibrillation (AF) patients with SLASEC or LAT. METHODS Nonvalvular AF patients scheduled to undergo catheter ablation or cardioversion in Shanghai Ruijin Hospital between January 2017 and July 2020 were screened for this prospective study. All patients underwent transesophageal echocardiography (TEE) to detect SLASEC or LAT. D-dimer concentrations were measured at the time of TEE. Clinical data including CHA2DS2-VASc score were evaluated. Major complications with thromboembolism in the SLASEC group were followed up at least 6 months after therapy. RESULTS Among 920 consecutively enrolled nonvalvular AF patients, 30 patients with SEC grade 0, 35 patients with SLASEC, and 22 patients with LAT were included. D-dimer concentration and CHA2DS2-VASc score were significantly lower in the SLASEC group compared with the LAT group (D-dimer, 0.26±0.13 vs. 0.86±0.9 mg/L, P<0.05; CHA2DS2-VASc score, 2.3±0.9 vs. 3.1±1.5, P=0.02). The cut-off value for D-dimer concentration (0.285 mg/L) had sensitivity of 77.3% and specificity of 80.0% for prediction of LAT. D-dimer concentration showed a decreasing trend with a significant difference (0.42±0.22 vs. 0.33±0.18 mg/L, P=0.03) for 9 patients in the LAT group after complete thrombus resolution by anticoagulation treatment. No major or fatal bleeding, ischemic stroke, or systemic thromboembolism events occurred in the SLASEC group during the 6-month follow-up. CONCLUSIONS This study demonstrated a significantly lower D-dimer concentration and CHA2DS2-VASc score in AF patients with SLASEC than in those with LAT. The D-dimer cut-off value (0.285 mg/L) can be used as an effective reference index to distinguish the pre-thrombotic state of LAT from LAT. D-dimer blood concentration may be a predictor of LAT thrombolysis.

UI MeSH Term Description Entries
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
November 2020, Thrombosis research,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
February 2015, International journal of cardiology,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
February 2021, Heart (British Cardiac Society),
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
July 2018, BMC cardiovascular disorders,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
January 2022, Frontiers in cardiovascular medicine,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
June 2018, Journal of geriatric cardiology : JGC,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
February 2022, Journal of thrombosis and thrombolysis,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
January 2022, The Journal of international medical research,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
April 2017, European journal of medical research,
Changjian Lin, and Yangyang Bao, and Wei Hua, and Ning Zhang, and Qi Jin, and Yun Xie, and Yue Wei, and Qingzhi Luo, and Zhuhui Liu, and Tianyou Ling, and Wenqi Pan, and Yucai Xie, and Liqun Wu
July 2022, BMC cardiovascular disorders,
Copied contents to your clipboard!